Clinico-Pathological Characteristics of HCV Coinfection in Chronic HBV Liver Diseases Patients in North-Central Nigeria
Umar M. S. *
Department of Internal Medicine, Jos University Teaching Hospital, Jos, Nigeria.
Malu A. O.
Department of Internal Medicine, Jos University Teaching Hospital, Jos, Nigeria.
Tanko M. N.
Department of Pathology, Jos University Teaching Hospital, Jos, Nigeria.
Okon K. O.
Department of Medical Microbiology, Federal Medical Centre, Makurdi, Nigeria.
Alkali M.
Department of Internal Medicine, Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, Nigeria.
Jibrin Y. B.
Department of Internal Medicine, Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, Nigeria.
Abdu A.
Department of Internal Medicine, Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, Nigeria.
Jacob A. D.
Department of Internal Medicine, Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, Nigeria.
Gwalabe S. A.
Department of Internal Medicine, Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, Nigeria.
Bem Tar
Department of Family Medicine, Federal Medical Centre, Makurdi, Nigeria.
Fika G. M.
Department of Internal Medicine, Yobe State University Teaching Hospital, Damaturu, Nigeria.
*Author to whom correspondence should be addressed.
Abstract
Introduction: Viral hepatitis (HBV, HCV) coinfection worsens patient diagnosis and management approach. Local clinical and pathological data provides a basic diagnostic information necessary for patient management. Hence, this study evaluated the clinico-pathological characteristics of HCV coinfection in chronic HBV liver disease patients.
Methodology: A total of 100 chronic HBV patients were enrolled into the study, with detailed demographic and clinical information documented into study database. Serodetection of HBsAg was determined by rapid immunochromatographic kit, and Anti-HCV by Enzyme-linked immunosorbent assay (ELISA)method. Haematological indices analysed using Systmex haematological analyser and biochemical profile, liver function tests by standard methods. The appropriate statistical method was applied in the analysis of study data.
Results: The 100 study patients comprised of 65% males and 35% females, male to a female ratio of 1.86:1, mean age of the coinfected patient was 42.0+8.8 years,with majority within the age-group of 41-50 years. Anti-HCV seroprevalence of 10%, 7(10.8%) males and 3(8.6%) females, M:F 1:2.3.Histological diagnosis of liver biopsies, 92% cases identified as chronic liver disease and 4% each as cirrhosis and hepatocellular carcinoma respectively. Anti-HCV detection in coinfected liver biopsies, 75% as hepatocellular carcinoma (HCC) cases, 25% as cirrhosis and 6.6% as chronic hepatitis. A significant association was observed between the severity of liver disease and degree of infection (p=0.01). Histological activity index score was significantly low in coinfected patients (5.2+4.2) compared with mono-infection (8.2+4.2) (p=0.01). There was a significant difference in the biochemical and haematological indices coinfected and monoinfected patients (<0.05).
Conclusion: The coinfection prevalence of 10% and the clinic-pathological picture were at variance with other Nigerian studies. The main findings revealed the concomitant contribution of both hepatic viruses to the development of chronic liver disease.
Keywords: HCV, HBV, coinfection, chronic liver disease, north-central Nigeria
How to Cite
Downloads
References
Marianna G Mavilia, George Y Wu. HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation Journal of Clinical and Translational Hepatology. 2018;6:296–305.
World Health Organization. New hepatitis data highlights need for urgent global response. Geneva (CH): World Health Organization; 2017.
Available:http://www.who.int/mediacentre/news/releases/2017/global-hepatitis-report/en/
Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45:529-538 [PMID: 16879891]
Raimondo G, Brunetto MR, Pontisso P, Smedile A, Maina AM, Saitta C, et al. Longitudinal evaluation reveals a complex spec-trum of virological profiles in hepatitis B virus/hepatitis Cvirus-coinfected patients. Hepatology. 2006;43(1):100—7.
Pol S, Haour G, Fontaine H, Dorival C, Petrov-Sanchez V, Bourliere M, et al. The negative impact of HBV/HCV coinfection on cirrhosis and its consequences. Aliment Pharmacol Ther. 2017;46:1054–1060.
DOI: 10.1111/apt.14352.
Chu CJ, Lee SD. Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and treatment. J Gastroenterol Hepatol. 2008;23:512 20.
Tyson GL, Kramer JR, Duan Z, Davila JA, Richardson PA, El- Serag HB. Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus infected patients. Hepatology. 2013;58:538-545
Olayinka AB, Oyemakinde B, Balogun MS, Ajudua A, Nguku P, Aderinola M, , et al Seroprevalence of Hepatitis B Infection in Nigeria: A National SurveyAm. J. Trop. Med. Hyg. 2016;95(4):902–907.
BM Musa, S Bussell , MM Borodo, AA Samaila, OL Femi Prevalence of hepatitis B virus infection in Nigeria, 2000-2013: A systematic review and meta-analysis Nigerian Journal of Clinical Practice. Mar-Apr 2015;18.
Laraba A, Wadzali G, Sunday B, et al. Hepatitis C Virus Infection in Nigerians with Chronic Liver Disease. Internet J Gastroenterol. 2009;9(1):1-3.
Lesi OA, Kehinde MO, Anomneze EE. Chronic liver disease in Lagos: A clinicopathological study. Niger Postgrad Med J. 2004;11:91-6.
Shehu MY. Prevalence of hepatitis C virus antibodies among patients with chronic liver disease at the Jos University Teaching Hospital. A dissertation submitted to the West African College of Physicians in partial fulfillment of the requirements for the award of Fellowship of the bb College; 2002.
Villari D, Pernice M, Spinella S, et al. Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study. Am J Gastroenterol. 1995;90:955-958.
Colombari R, Dhillon AP, Piazzola E et al. Chronic hepatitis in multiple virus infection: histopathological evaluation. Histopathology. 1993;22:319–25.
Sagnelli E, Pasquale G, Coppola N, Scarano F, Marrocco C, Scolastico C, et al. Influence of Chronic Coinfection with Hepatitis B and C Virus on Liver HistologyInfection. 2004;32:144–148.
Wesly A, Altar MJ. Epidemiology of hepatitis C: Geographical differences and temporal trends. Semin Liver Dis. 2000; 20:1.
Grewal US, Walia G, Bakshi R, Chopra S. Hepatitis B and C Viruses, their coinfection and correlations in chronic liver disease patients: A tertiary care hospital study. Int J App Basic Med Res. 2018;8:204-9.
Amarjit Kaur Gill, Vivek Mittal, Vanita Mittal, Narinder Kaur, Amandeep Kaur, A K Maria, Rajinder Singh Seroprevalence of HBsAg, anti-HCV and co-infection among liver disease patients: A prospective observational trial. International Journal of Contemporary Medical Research. 2016; 3(8):2204-2208.
Dai CY, Yu ML, Chuang WL et al. Influence of hepatitis C virus on the profiles of patients with chronic hepatitis B virus infection. J. Gastroenterol. Hepatol. 2001; 16:636–40
Hossani MM, Khandaker MAK, Azad KAK, Sardar MH, Deb SR, Mallik MU. Clinicopathological correlation of liver biopsy- study of 50 cases J Dhaka Med Coll. 2013;22(2):120-124.
Prabha Desikan, Aseem Rangnekar, Zeba Khan, Nikita Panwalkar, Protiti Bose, Hanni Vasudev Gulwani, et al. Sero-Occurrence of HBV/HCV Co-infection and Levels of Liver Enzymes among Patients at a Tertiary Care Hospital in Central India: a Pilot Study. Central Asian Journal of Global Health. 2019;8(1).
Ohkawa K, Hayashi N, Yuki N, Hagiwara H, Kato M, Yamamoto K, et al. Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients. J Hepatol. 1994;21:509-514
Chowdhury AW. A Study of HBsAg status of hospital admitted patients of chronic liver disease and its clinicopathological correlation [Dissertation]. Dhaka: Bangladesh College of Physicians and Surgeons (BCPS); 1995.
Singh V, Katyal R, Kochhar RK, Bhasin DK, Aggarwal RP. Study of hepatitis B and C viral markers in patients of chronic liver disease. Indian J Med Microbiol. 2004; 22:269 70.
Devi KS, Singh NB, Mara J, Singh TB, Singh YM.Seroprevalence of hepatitis B virus and hepatitis C virus among hepatic disorders and injecting drug users in manipur – A preliminary report. Indian J Med Microbiol. 2004;22:136 7.
Fong TL, Di Bisceglie AM, Waggoner JG, et al. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology. 1992;14:64-7.
Crespo J, Lozano J C, de la Cruz F et al. Prevalence and significance of hepatitis C. Viremia in chronic active hepatitis B. AM. J. Gestroenterol. 1994;89:1147-51
Chakravarti A, Verma V, Jain M, Kar P. Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease: A study from tertiary care hospital. Trop Gastroenterol. 2005; 26(4):183–7.
Olubuyide IO, Aliyu B, Olaleye OA, Ola SO, Olawuyi F, Malabu UH, et al. Hepatitis B and C virus and Hepatocellular carcinoma. Trans R Soc Trop Med Hyg. 1997;91(1):38-41.
Saravanan S, Velu V, Nandakumar S, Madhavan V, Shanmugasundaram U, Murugavel KG, et al. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease. J Microbiol Immunol Infect. 2009;42:122-128.
Tsatsralt-Od B, Takahashi M, Nishizawa T, Endo K, Inoue J, Okamoto H. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. J Med Virol. 2005;77:491- 499.
Kirk GD, Lesi OA, Mendy M, et al. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology. 2004;39:211–19.
Anderson E, Ridly DS. Liver biopsy and precutaneous cholangiography using posterior approach 500 needle biopsy. Am J Surg. 2003;121:31-42.
Bruix J. Barnera Jm, Calvet x et al. prevalence of antibodies to hepatitis C virus in Spanish pa;tients with hepatocellular carcinoma. Lancet. 1989;2:1004-1009.
Yuki N, Hayeshi N, Kasahare A, et al hepatitis B virus maker and antibodies to hepatitis C virus in Japan patients with hepstocellular carcinoma. Digestive Diseases and Science. 1992;37:65-72.
Colombo M, Kuo G, Choo QL, et al. Prevalence of anti bodies to hepatitis C virus in Halian patients with hepstocellular carcinoma. Lancet. 1989;2:1006-1008.
Ola SO, Odaibo GN, Olaleye OD. HCV and HBV infections in Nigerian patients with Liver cirrhosis and Hepatocellular carcinoma. Nig Q J Hosp Med. 2004;14.
Konstantinou D, Deutsch M. The spectrum of HBV/HCV coinfection: Epidemiology, clinical characteristics, viralinteractions and management. Ann Gastroenterol. 2015; 28:221–228.
Huang YT, Jen CL, Yang HI, Lee MH, Su J, Lu SN, Iloeje UH, Chen CJ. Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. J Clin Oncol. 2011; 29:3643-3650.
PMID: 21859997. DOI: 10.1200/JCO.2011.36.2335
Aghemo A, Colombo M. Treatment of patients with dual hepatitis B and C: A step in the right direction. Gut. 2014;63.
Lee LP, Dai CY, Chuang WL, et al. Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C-co-infected patients. J. Gastroenterol. Hepatol. 2007; 22:515–17.
Liu Z, Hou J. Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection, international Journal of Medical Sciences. 2006;3(2):57–62.
Chen CH, Yang PM, Huang GT, Lee HS, Sung JL, Sheu JC. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants, Journal of the Formosan Medical Association. 2007;106(2):148–155.
Marrot A, Belaid A, Orlent H, Sersté T, Michielsen P, Colle I, et al. Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients. Clin Res Hepatol Gastroenterol. 2017;41:656– 663.
Zarski JP, Bohn B, Bastie A, Pawlotsky JM, Baud M, Bost-Bezeaux F, et al.Characteristics of patients with dual infection by hepatitis B and C viruses.J Hepatol. 1998;28:27–33.
Senturk H, Tahan V, Canbakan B, Dane F, Ulger Y, Ozaras R, et al. Clinicopathologic features of dual chronic hepatitis B and C infection: a comparison with single hepatitis B, C and delta infections. Ann Hepatol. 2008;7(1):52–8.
Abdullah SM. Prevalence of Hepatitis B and C virus infection and their co-relation with hematological and hepatic parameters in subjects undergoing Premarital Screening in the Jazan Region, Kingdom of Saudi Arabia. Pak J Med Sci. 2018; 34(2):316-321.
Prabha Desikan, Aseem Rangnekar, Zeba Khan, Nikita Panwalkar, Protiti Bose, Hanni Vasudev Gulwani, Sukhpreet Kaur. Sero-Occurrence of HBV/HCV Co-infection and Levels of Liver Enzymes among Patients at a Tertiary Care Hospital in Central India: a Pilot Study. Central Asian Journal of Global Health. 2019;8(1).
Garcovich M, Zocco MA, Gasbarrini A. Clinical use of albumin in hepatology. Blood Transfus. 2009;7(4):268-277.
Fasola FA, Otegbayo JA, Abjah UMA and Ola SA. Heamatological parameters in Nigerians with acute viral hepatitis. Nigerian Journal of Gastroenterology and Hepatology. 2009;1(1):27-31
Mohamed AE, Ven D, Al Karawi MA. Dual infection with hepatitis C and B viruses: clinical and histologic study in Saudi patients. Hepatogastroenterology. 1997; 44:1404–6.
Nezam Afdhal, John McHutchison, Robert Brown, Ira Jacobson, Michael Manns, Fred Poordad, et al. Thrombocytopenia associated with chronic liver disease Journal of Hepatology. 2008;48:1000–1007.
Ajugwo AO, Ukaji DC. Some Haematological Parameters of Symptomatic and Asymptomatic Hepatitis B Positive Patients Attending a Nigerian Tertiary Hospital. British Journal of Medicine and Medical Research. 2015 ;7(3):219-223.